Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system

Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system

US Patent 6194428 · Granted Feb 27, 2001

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted dihydroquinazolines2023
Polyethylene glycol based prodrug of adrenomedullin and use thereof2018
Substituted dihydroquinazolines2018
Polyethylene glycol based prodrug of adrenomedullin and use thereof2017
Substituted phenylureas and phenylamides as vanilloid receptor ligands2017
Polyethylene glycol based prodrug of adrenomedullin and use thereof2017
Tyrosine based linkers for the releasable connection of peptides2016
2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity f2015
Substituted phenylureas and phenylamides as vanilloid receptor ligands2015
Substituted phenylureas and phenylamides as vanilloid receptor ligands2015
Vanilloid receptor ligands, pharmaceutical compositions containing them, process2014
Vanilloid receptor ligands, pharmaceutical compositions containing them, process2014